DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Baker - 1 Tisch - 1 Julian - 1 Felix Baker - 1 Seagen - 1 Yun Li - 1
Top related locs:
InVitae Invitae Acadia ImmunoGen
Top related orgs:
Baker Bros - 1 Advisors - 1 Yale - 1 Acadia Pharmaceuticals - 1 Kymera Therapeutics - 1

Search resuls for: "Felix Baker"


2 mentions found


☆ A biotech hedge fund that counts Yale’s endowment among its clients bought a new stake in this genetic testing company
  + stars: | 2023-08-16 | by ( Sarah Min | ) www.cnbc.com   time to read: +1 min
Founded by brothers Julian and Felix Baker in 2000, the health care hedge fund focuses on biotech and life sciences investing. The biotech stock with a focus on neuroscience has surged more than 84% this year. Baker Bros. doubled down on its bet in Kymera Therapeutics , which it raised by more than 51%. The hedge fund also took new stakes in ImmunoGen , which has more than tripled this year, soaring 216%, and Day One Biopharmaceuticals , which is down by 34%. The hedge fund lowered its exposure to the biotech company, which develops treatments for cancer, by 5%.
Persons: Baker, Tisch, Julian, Felix Baker, Seagen, Yun Li Organizations: Baker Bros, Advisors, Yale, Acadia Pharmaceuticals, Kymera Therapeutics Locations: InVitae, Invitae, Acadia, ImmunoGen
☆ This biotech hedge fund has elite clients like Yale’s endowment, Tisch. Here are its top bets
  + stars: | 2023-02-17 | by ( Yun Li | ) www.cnbc.com   time to read: +2 min
Baker Bros. Advisors, a secretive hedge fund that counts Yale University's endowment and the Tisch family as its clients, held onto a slew of its favorite biotech names last quarter. Its portfolio has grown to be the 15th-biggest among U.S. hedge funds through 2022, according to FactSet, despite its lack of notoriety. The hedge fund specializes in biotech investing as the founders, now in their 50s, take advantage of their educational background in immunology, riding on the explosive growth in the sector over the past decade. Meanwhile, Yale's charitable foundation has invested in 667 LP — a Baker Bros. vehicle — since at least 2009. The hedge fund slightly increased its exposure to Madrigal Pharmaceuticals and Rhythm Pharmaceuticals last quarter, the filing showed.
0 next >>
Total: 2